TARA Q3 2017 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$216M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-27.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$747,000

Balance Sheet

Total Assets

$49M

Total Liabilities

$9M

Stockholders' Equity

$39M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$12M	-$7M	-71.7%
Net Income	-$12M	-$7M	-73.1%